Hematology Analyzers and Reagents Market

Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023

Report Code: MD 2479 Jun, 2018, by marketsandmarkets.com

The global hematology analyzers and reagents market is expected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market. Furthermore, factors such as technological advancements in hematology analyzers and reagents and integration of flow cytometry techniques with hematology analyzers are expected to support the growth of this market during the forecast period.

Hematology Analyzers and Reagents Market

By products and services, the hematology products and services segment is expected to be the largest segment of the market in 2017

Based on products and services, the hematology analyzers and reagents market is classified into hematology, hemostasis, and immunohematology products and services. The hematology products and services segment accounted for the largest market share in 2017. This can be attributed to the increasing adoption of POC testing hematology analyzers in emerging economies, launch of technologically advanced hematology products coupled with the increasing preference towards automation, and rising trend of the ‘reagent rental’ business model, and the availability of a wide range of services from major hematology providers.

By price range, the high-end hematology analyzers segment is expected to grow at the highest rate during the forecast period

On the basis of price range, the hematology instruments market is classified into high-end, mid-range, and low-end Hematology Analyzers. The high-end Hematology Analyzers segment is expected to grow at the highest rate in 2017. This is attributed to advanced features of high-end analyzers such as reliability, high accuracy, flexibility, ease of use, and multi-parameter testing capability.

Hematology Analyzers and Reagents Market

North America dominated the market in 2017

North America accounted for the largest share of the global hematology products and services market in 2017, followed by Europe. This is attributed due to factors such as the rising incidence of patients suffering from blood disorders, high number of patients with blood coagulation disorders, growing prevalence of target diseases, and the rising demand for blood transfusions are increasing the demand for hematology testing in North America.

Hematology Analyzers and Reagents Market

Market Dynamics

The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market. Furthermore, factors such as technological advancements in hematology analyzers and reagents and integration of flow cytometry techniques with hematology analyzers are expected to support the growth of this market. However, the high cost of hematology analyzers, product recalls, and the slow adoption of advanced hematology instruments in emerging countries are expected to restrain the growth of this market.

Driver: Increasing incidence of blood disorders

Hematology analyzers are used to count and characterize blood cells for the diagnosis and monitoring of various blood disorders. High-end, refined analyzers help in detecting rare blood conditions such as Eosinophilia and Histiocytosis, by measuring the cell morphology and detecting small cell populations. As a result, it is estimated that the demand for hematology analyzers will increase with the rising incidence of blood-related disorders such as haemophilia, anemia, lymphoma, autoimmune disorders, and blood cancers. For instance,

  • The American Red Cross has estimated that sickle cell anemia affects more than 80,000 people in the US. Severe anaemic patients require blood transfusions to restore the normal level of RBCs in their blood.
  • Furthermore, according to the American Red Cross, around 21 million blood transfusions are performed every year in the US.

Restraint: Product recalls and safety alerts

Over the last few years, the market has witnessed a large number of recalls of hematology analyzers majorly due to inaccurate results. Some of these developments have been mentioned below:

  • In June 2017, Beckman Coulter (US) recalled the Coulter Hematology Analyzers—LH 750, LH 500, LH 780, and HmX. These products were recalled after the detection of inaccuracies in terms of flagging or detecting blasts in some blood samples.
  • In April 2017, Sysmex (Japan) sent a Field Correction letter for its XN Series of automated hematology analyzers owing to safety alerts as instances where analyzers caught fire were reported.
  • In October 2016, Siemens (Germany) issued an Urgent Field Safety Notice (UFSN) for its ADVIA 560 Hematology System after receiving multiple discordant records for the same sample in the database occurring during system installation.
  • In March 2016, Drew Scientific (US) recalled the D3 Hematology AnalyzerD3 Reagent pack as its use could potentially result in elevated platelet background during Drew3 Hematology Analyzer routine checks.

These recalls not only affect consumer confidence but also hamper the reputation of leading players in the market. Thus, such recalls are expected to affect the growth of the hematology analyzers market to a certain extent in the coming years.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2016-2023

Base Year Considered

2017

Forecast Period

2018–2023

Forecast Units

Value (USD)

Segments Covered

Products and service, price range, end user, and region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW  

Companies Covered

Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (US), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland)

This report categorizes the hematology analyzers and reagents market into the following segments and subsegments:

Global Hematology Analayzers and Reagents Market, by Type

  • Hematology Products & Services
    • Instruments
      • 5-Part and 6-Part Fully Automated Hematology Analyzers
      • 3-Part Fully Automated Hematology Analyzers
      • Semi-Automated Hematology Analyzers
      • Point-Of-Care Testing Hematology Analyzers
    • Reagents & Consumables
      • Hematology Reagents
      • Slide Stainers/Makers
      • Controls and Calibrators
      • Consumables
    • Services
  • Hemostasis Products & Services
    • Instruments
    • Reagents & Consumables
    • Services
  • Immunohematology Products & Services
    • Instruments
    • Reagents & Consumables
    • Services

Global Hematology Analyzers and Reagents Market, by Price Range

  • High-End Hematology Analyzers
  • Mid-Range Hematology Analyzers
  • Low-End Hematology Analyzers

Global Hematology Analyzers and Reagents Market, By End User

  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes

Global Hematology Analyzers and Reagents Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Key Market Players

As of 2017, the global hematology market was dominated by Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (US), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).

Sysmex (Japan) held the leading position in the global hematology market. The company is an integrated supplier of instruments and reagents in the field of diagnostics. The company focuses on expansions, agreements, and new product launches to ensure its growth in the hematology analyzers and reagents market. In line with this, the company launched XN-9100, XN-3100, XN-1500, XN-L, and SP-50 (an automated hematology slide preparation unit). By adopting inorganic and organic growth strategies, the company has improved its sales and support networks in emerging markets, which has helped it maintain its leading position in the hematology analyzers and reagents market. Thus, the company’s efforts to develop technologically advanced hematology products are fueling the growth of its hematology business operations.

Danaher (US) held the second position in the global hematology market. To maintain its market position and ensure future growth, the company adopted organic and inorganic growth strategies. In line with this, Danaher acquired Beckman Coulter which helped it to expand its hematology analyzers business. Furthermore, Danaher focuses on its R&D to provide its customers with innovative products and maintain its competitive position in the market. The company’s efforts to strengthen its product portfolio, expand its geographic reach, and increase brand visibility are expected to drive its growth in the hematology market.

Recent Developments:

  • In January 2018, Bio-Rad launched IH-Incubator L and IH-Centrifuge L Instruments
  • In August 2017, Abbott and NWLP signed an equipment services contract for the supply of Abbott's Alinity ci and Alinity h series diagnostics instruments along with AlinIQ (Abbott’s professional information services and informatics solutions) to NWLP.
  • In November 2017, Nihon Kohden established a new sales branch in Kenya, namely, Nihon Kohden Middle East (NKME) in order to expand its business in East Africa.
  • In November 2016, HORIBA India opened a new technical center in Pune, India. This center serves as a base for emission measurement systems and advanced analytical instruments.
  • In June 2017, Nihon Kohden Corporation merged its Span Nihon Kohden Diagnostics Pvt. Ltd. subsidiary, (manufactures and distributes hematology reagents in India) into Nihon Kohden India Pvt. Ltd. in order to expand its hematology business in India.

Key questions addressed in the report:

  • What are the growth opportunities related to hematology analyzers and reagents market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of point-of-care testing hematology analyzers. Will this scenario continue in the next five years?
  • What are the various types of hematology instruments and their market share in the overall market?
  • What are the new trends and advancements in the reagents & consumables segment?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
           1.3.1 Years Considered for the Study
    1.4 Currency Used
    1.5 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Methodology Steps
    2.2 Secondary Research
    2.3 Primary Research
    2.4 Market Size Estimation Methodology
           2.4.1 Bottom-Up Approach
           2.4.2 Top-Down Approach
    2.5 Market Breakdown and Data Triangulation
    2.6 Research Assumptions
    2.7 Research Limitations

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Hematology Analyzers and Reagents Market Overview
    4.2 Hematology Analyzers and Reagents Market, By Product and Service, 2018 Vs. 2023 (USD Million)
    4.3 Hematology Instruments Market, By Price Range, 2018 Vs. 2023 (USD Million)
    4.4 Hematology Products and Services Market, By End User, 2018 Vs. 2023 (USD Million)
    4.5 Hematology Instruments Market, By Country (2018–2023)

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rise in Blood Donation
                    5.2.1.2 Increasing Incidence of Blood Disorders
                    5.2.1.3 Technological Advancements
                    5.2.1.4 Integration of Hematology Analyzers With Flow Cytometry
           5.2.2 Restraints
                    5.2.2.1 Product Recalls and Safety Alerts
                    5.2.2.2 Slow Adoption of Advanced Hematology Instruments in Emerging Countries
           5.2.3 Opportunities
                    5.2.3.1 Growing use of Automated Hematology Analyzers
                    5.2.3.2 Market Penetration Opportunities in Emerging Countries
                    5.2.3.3 Rising Awareness Among End Users About Advanced Hematology Analyzers
                    5.2.3.4 Emergence of Microfluidics Technology
           5.2.4 Challenges
                    5.2.4.1 High Cost of Advanced Hematology Analyzers
                    5.2.4.2 Stringent and Time-Consuming Regulatory Processes Significantly Increasing the Gestation Period for Product Launches
           5.2.5 Industry Trend
                    5.2.5.1 Growing Reagent Rental Business

6 Hematology Analyzers and Reagents Market, By Product & Service (Page No. - 45)
    6.1 Introduction
    6.2 Hematology Products & Services
           6.2.1 Instruments
                    6.2.1.1 5-Part and 6-Part Fully Automated Hematology Analyzers
                    6.2.1.2 3-Part Fully Automated Hematology Analyzers
                    6.2.1.3 Semi-Automated Hematology Analyzers
                    6.2.1.4 Point-Of-Care Testing Hematology Analyzers
           6.2.2 Reagents & Consumables
                    6.2.2.1 Hematology Reagents
                    6.2.2.2 Slide Stainers/Makers
                    6.2.2.3 Controls and Calibrators
                    6.2.2.4 Consumables
           6.2.3 Services
    6.3 Hemostasis Products & Services
           6.3.1 Instruments
           6.3.2 Reagents & Consumables
           6.3.3 Services
    6.4 Immunohematology Products & Services
           6.4.1 Instruments
           6.4.2 Reagents & Consumables
           6.4.3 Services

7 Hematology Instruments Market, By Price Range (Page No. - 70)
    7.1 Introduction
    7.2 High-End Hematology Analyzers
    7.3 Mid-Range Hematology Analyzers
    7.4 Low-End Hematology Analyzers

8 Hematology Instruments Market, By Application (Page No. - 73)
    8.1 Introduction
    8.2 Anemia
    8.3 Blood Cancer
    8.4 Hemorrhagic Conditions
    8.5 Infection Related Conditions
    8.6 Immune System Related Conditions
    8.7 Other Applications

9 Hematology Products and Services Market, By End User (Page No. - 75)
    9.1 Introduction
    9.2 Hospital Laboratories
    9.3 Commercial Service Providers
    9.4 Government Reference Laboratories
    9.5 Research and Academic Institutes

10 Hematology Analyzers and Reagents Market, By Region (Page No. - 83)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Rest of Europe
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
             10.4.1 Brazil
             10.4.2 Mexico
             10.4.3 Rest of Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 114)
     11.1 Introduction
     11.2 Hematology Analyzers and Reagents Market Share Analysis, By Top 3 Global Players (In Terms of %Revenue Share as of 2017)
     11.3 Competitive Scenerio (2015-2018)
             11.3.1
             11.3.2 Partnerships and Collaborations
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions
     11.4 Competitive Leadership Mapping (For 25 Major Market Players)
             11.4.1 Vendor Inclusion Criteria
                       11.4.1.1 Visionary Leaders
                       11.4.1.2 Innovators
                       11.4.1.3 Dynamic Differentiators
                       11.4.1.4 Emerging Companies
     11.5 Competitive Leadership Mapping (For Start-Ups/Emerging Companies)
             11.5.1 Vendor Inclusion Criteria
                       11.5.1.1 Progressive Companies
                       11.5.1.2
                       11.5.1.3 Responsive Companies
                       11.5.1.4 Dynamic Companies

12 Company Profiles (Page No. - 119)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     12.1 Abbott
     12.2 Bio-Rad Laboratories
     12.3 BioSystems (A Part of Ginper Group)
     12.4 Boule
     12.5 Danaher
     12.6 Diatron
     12.7 Drew Scientific
     12.8 EKF Diagnostics
     12.9 HORIBA
     12.10 Mindray
     12.11 Nihon Kohden
     12.12 Ortho Clinical Diagnostics
     12.13 Roche
     12.14 Siemens
     12.15 Sysmex

*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 160)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (83 Tables)

Table 1 Number of Blood Donations, By Country (2015)
Table 2 Hematology Analyzers and Reagents Market, By Product & Service, 2016–2023 (USD Million)
Table 3 Hematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 4 Hematology Products & Services Market, By Region, 2016–2023 (USD Million)
Table 5 Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 6 Hematology Instruments Market, By Region, 2016–2023 (USD Million)
Table 7 5-Part and 6-Part Fully Automated Hematology Analyzers Market, By Region, 2016–2023 (USD Million)
Table 8 3-Part Fully Automated Hematology Analyzers Market, By Region, 2016–2023 (USD Million)
Table 9 Semi-Automated Hematology Analyzers Market, By Region, 2016–2023 (USD Million)
Table 10 Point-Of-Care Testing Hematology Analyzers Market, By Region, 2016–2023 (USD Million)
Table 11 Hematology Reagents & Consumables Market, By Type, 2016–2023 (USD Million)
Table 12 Hematology Reagents and Consumables Market, By Region, 2016–2023 (USD Million)
Table 13 Hematology Reagents Market, By Region, 2016–2023 (USD Million)
Table 14 Hematology Slide Stainers/Makers Market, By Region, 2016–2023 (USD Million)
Table 15 Hematology Controls and Calibrators Market, By Region, 2016–2023 (USD Million)
Table 16 Hematology Consumables Market, By Region, 2016–2023 (USD Million)
Table 17 Hematology Services Market, By Region, 2016–2023 (USD Million)
Table 18 Hemostasis Products & Services Market, By Type, 2016–2023 (USD Million)
Table 19 Hemostasis Products & Services Market, By Region, 2016–2023 (USD Million)
Table 20 Hemostasis Instruments Market, By Region, 2016–2023 (USD Million)
Table 21 Hemostasis Reagents & Consumables Market, By Region, 2016–2023 (USD Million)
Table 22 Hemostasis Services Market, By Region, 2016–2023 (USD Million)
Table 23 Immunohematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 24 Immunohematology Products & Services Market, By Region, 2016–2023 (USD Million)
Table 25 Immunohematology Instruments Market, By Region, 2016–2023 (USD Million)
Table 26 Immunohematology Reagents & Consumables Market, By Region, 2016–2023 (USD Million)
Table 27 Immunohematology Services Market, By Region, 2016–2023 (USD Million)
Table 28 Hematology Instruments Market, By Price Range, 2016–2023 (USD Million)
Table 29 High-End Hematology Instruments Market, By Region, 2016–2023 (USD Million)
Table 30 Mid-Range Hematology Analyzers Market, By Region, 2016–2023 (USD Million)
Table 31 Low-End Hematology Instruments Market, By Region, 2016–2023 (USD Million)
Table 32 Hematology Instruments Market, By Application, 2016–2023 (USD Million)
Table 33 Hematology Instruments Market for Anemia, By Region, 2016–2023 (USD Million)
Table 34 Hematology Instruments Market for Blood Cancer, By Region, 2016–2023 (USD Million)
Table 35 Hematology Instruments Market for Hemorrhagic Conditions, By Region, 2016–2023 (USD Million)
Table 36 Hematology Instruments Market for Infection Related Conditions, By Region, 2016–2023 (USD Million)
Table 37 Hematology Instruments Market for Immune System Related Conditions, By Region, 2016–2023 (USD Million)
Table 38 Hematology Instruments Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 39 Hematology Products & Services Market, By End User, 2016–2023 (USD Million)
Table 40 Hematology Products & Services Market for Hospital Laboratories, By Region, 2016–2023 (USD Million)
Table 41 Hematology Products & Services Market for Commercial Service Providers, By Region, 2016–2023 (USD Million)
Table 42 Hematology Products & Services Market for Government Reference Laboratories, By Region, 2016–2023 (USD Million)
Table 43 Hematology Products & Services Market for Research and Academic Institutes, By Region, 2016–2023 (USD Million)
Table 44 Hematology Products & Services Market, By Region, 2016–2023 (USD Million)
Table 45 Hemostasis Products & Services Market, By Region, 2016–2023 (USD Million)
Table 46 Immunohematology Products & Services Market, By Region, 2016–2023 (USD Million)
Table 47 North America: Hematology Instruments Market, By Country, 2016–2023 (USD Million)
Table 48 North America: Hematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 49 North America: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 North America: Hematology Instruments Market, By Price Range, 2016–2023 (USD Million)
Table 51 North America: Hematology Products & Services Market, By End User, 2016–2023 (USD Million)
Table 52 North America: Hemostasis Products & Services Market, By Type, 2016–2023 (USD Million)
Table 53 North America: Immunohematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 54 US: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 55 Canada: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 56 Europe: Hematology Instruments Market, By Country, 2016–2023 (USD Million)
Table 57 Europe: Hematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 58 Europe: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 59 Europe: Hematology Instruments Market, By Price Range, 2016–2023 (USD Million)
Table 60 Europe: Hematology Products & Services Market, By End User, 2016–2023 (USD Million)
Table 61 Europe: Hemostasis Products & Services Market, By Type, 2016–2023 (USD Million)
Table 62 Europe: Immunohematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 63 Germany: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 64 France: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 65 UK: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 66 RoE: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 67 APAC: Hematology Instruments Market, By Country, 2016–2023 (USD Million)
Table 68 APAC: Hematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 69 APAC: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 70 APAC: Hematology Instruments Market, By Price Range, 2016–2023 (USD Million)
Table 71 APAC: Hematology Products & Services Market, By End User, 2016–2023 (USD Million)
Table 72 APAC: Hemostasis Products & Services Market, By Type, 2016–2023 (USD Million)
Table 73 APAC: Immunohematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 74 Japan: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 75  China: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 76 India: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 RoAPAC: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 78 RoW: Hematology Products & Services Market, By Type, 2016–2023 (USD Million)
Table 79 RoW: Hematology Instruments Market, By Type, 2016–2023 (USD Million)
Table 80 RoW: Hematology Instruments Market, By Price Range, 2016–2023 (USD Million)
Table 81 RoW: Hematology Products & Services Market, By End User, 2016–2023 (USD Million)
Table 82 RoW: Hemostasis Products & Services Market, By Type, 2016–2023 (USD Million)
Table 83 RoW: Immunohematology Products & Services Market, By Type, 2016–2023 (USD Million)
 
 
List of Figures (42 Figures)
 
Figure 1 Research Design
Figure 2 Key Data From Secondary Sources
Figure 3 Key Data From Primary Sources
Figure 4 Breakdown of Primaries
Figure 5 Bottom-Up Approach
Figure 6 Top-Down Approach
Figure 7 Data Triangulation
Figure 8 Assumptions of the Research Study
Figure 9 Hematology Analyzers and Reagents Market, By Product & Service, 2018 Vs. 2023 (USD Million)
Figure 10 Hematology Instruments Market, By Price Range, 2018 Vs. 2023 (USD Million)
Figure 11 Hematology Products and Services Market, By End User (2018)
Figure 12 Hematology Products and Services Market, By Region (2017)
Figure 13 Increasing Incidence of Blood Disorders to Drive the Hematology Analyzers & Reagents Market During 2018–2023
Figure 14 Hematology Products and Services Segment Will Continue to Dominate the Market in 2023
Figure 15 Low-End Hematology Analyzers to Dominate the Hematology Instruments Market in 2018 vs 2023
Figure 16 Commercial Service Providers to Dominate the Hematology Products and Services Market in 2018
Figure 17 China to Register the Highest CAGR in the Hematology Instruments Market During the Forecast Period
Figure 18 Hematology Analyzers and Reagents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Annual Healthcare Expenditure (% of GDP): Developed Vs. Developing Countries (2010 Vs. 2014)
Figure 20 Hematology Products and Services Market to Garner Higher Revenue Compared to Hemostasis and Immunohematology Segments Till 2023
Figure 21 Reagents & Consumables Segment to Dominate the Hematology Products & Services Market During the Forecast Period
Figure 22 5 & 6-Part Fully Automated Hematology Analyzers Segment to Dominate the Hematology Instruments Market During the Forecast Period
Figure 23 Reagents and Consumables Segment to Dominate the Hemostasis Products & Services Market During the Forecast Period
Figure 24 Reagents & Consumables to Dominate the Immunohematology Products & Services Market During the Forecast Period
Figure 25 Low-End Hematology Analyzers Segment to Dominate the Hematology Instruments Market, By Price Range, During the Forecast Period
Figure 26 Commercial Service Providers to Dominate the Hematology Products & Services Market During the Forecast Period
Figure 27 North America: Hematology Products and Services Market Snapshot
Figure 28 Europe: Hematology Products and Services Market Snapshot
Figure 29 APAC: Hematology Products and Services Market Snapshot
Figure 30 RoW: Hematology Products and Services Market Snapshot
Figure 31 Key Developments By Leading Market Players in the Market, 2015–2018
Figure 32 Global Hematology Analyzers and Reagents Market Share, Key Player (2017)
Figure 33 Abbott: Company Snapshot
Figure 34 Bio-Rad Laboratories: Company Snapshot
Figure 35 Boule Diagnostics: Company Snapshot
Figure 36 Danaher: Company Snapshot
Figure 37 EKF Diagnostics: Company Snapshot
Figure 38 HORIBA: Company Snapshot
Figure 39 Nihon Kohden: Company Snapshot
Figure 40 Roche Diagnostics: Company Snapshot
Figure 41 Siemens: Company Snapshot
Figure 42 Sysmex: Company Snapshot

This study involved four major activities in estimating the current size of the hematology analyzers and reagents market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about market classification and segmentation, identification of key industry trends, regional scenario, and key developments undertaken by major European market players. Secondary sources include World Bank (US), Organization for Economic Co-operation and Development (OECD), U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and GLOBOCAN, annual reports, press releases, and investor presentations of companies, white papers, certified publications, as well as articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the hematology analyzers and reagents market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side [such as research and academic institutes, commercial/private laboratories (mid-small sized), and purchase managers in government laboratories] and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of the hematology analysers and reagents segment, and senior managers, suppliers, channel partners, and distributors) across Germany, the UK, France, Italy, Spain, and other European countries. Approximately 30% and 70% of primary interviews were conducted with the demand and supply sides, respectively. This primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

Hematology Analyzers and Reagents Market - Breakdown of Primary Interviews

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

"A detailed market estimation approach was followed to estimate and validate the size of the hematology analyzers and reagents market and other dependent submarkets.

  • The key players in the hematology analyzers and reagents market were identified through detailed market analysis, and their market revenue/ranking was estimated through primary and secondary research
  • Annual and quarterly financial reports of the top market players were studied along with interviews from industry experts to gather key insights on various market segments and subsegments
  • All segmental shares, splits, and breakdowns were determined by using secondary data sources and verified through primary respondents
  • Major macro indicators that affect market dynamics at the segment and sub-segment level have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to finalize the quantitative and qualitative market estimations
  • The above-mentioned data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation:

After deriving the hematology analyzers and reagents market value data from the market estimation process explained above, the total market value data was split into several segments. Data triangulation and market breakdown were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing country-based trends for both the demand-and supply-side macro indicators.

Report Objectives:

  • To define, describe, and forecast the global hematology analyzers and reagents market by products & services, price range, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the market value of market segments in North America (US, Canada), Europe (Germany, France, UK, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), and the Rest of the World
  • To profile the key players in the global hematology analyzers and reagents market and comprehensively analyze their market rank and core competencies2
  • To track and analyze competitive developments such as product launches, and approvals; partnerships, agreements, and collaborations; acquisitions; and expansions in the global hematology analyzers and reagents market

Scope of the Report

Report Metric

Details

Market Size Available for Years

2016–2023

Base Year Considered

2017

Forecast Period

2018–2023

Currency Used

Value (USD Million)

Segments Covered

Product & service, Price Range, End User, and Country

Countries Covered

US, Canada, Germany, the UK, France, RoE, Japan, China, India, RoAPAC

Companies Covered

15 major players, including Sysmex (Japan), Danaher (US), Nihon Kohden (Japan), Siemens (Germany), and Abbott Laboratories (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland).

In this report, the hematology analyzers and reagents market has been segmented based on product & service, price range, end user, and region.

Hematology Analyzers And Reagents Market, By Product & Service

  • Instruments
    • 5-part and 6-part fully automated hematology analyzers
    • 3-part fully automated hematology analyzers
    • Semi-automated hematology analyzers
    • Point-of-care testing hematology analyzers
  • Reagents & consumables
    • Hematology reagents
    • Slide stainers/makers
    • Controls and calibrators
    • Consumables
  • Services
  • Hemostasis products & services
    • Instruments
    • Reagents and consumables
    • Services
  • Immunohematology products and services
    • Instruments
    • Reagents and consumables
    • Services

Hematology Instruments Market, by Price range

  • High-end hematology analyzers
  • Mid-range hematology analyzers
  • Low-end hematology analyzers

Hematology Products and Services Market, by End User

  • Hospital laboratories
  • Commercial service providers 
  • Government reference laboratories
  • Research and academic institutes

Hematology Analyzers and Reagents Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the hematology analyzers and reagents market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the hematology analyzers and reagents market

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 2479
Published ON
Jun, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hematology Analyzers and Reagents Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home